Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.49 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CA7 | P43166 | 1/20 | 0.49 |
| ▸ | CA9 | Q16790 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | POLA1 | P09884 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18723242 | 1.00 | ZDHHC7 (0.50) | ZDHHC7CA12CA14CA2CA7 | |
| SCHEMBL25542871 | 1.00 | ZDHHC7 (0.50) | ZDHHC7CA12CA14CA2CA7 | |
| SCHEMBL21499118 | 1.00 | ZDHHC7 (0.50) | ZDHHC7CA12CA14CA2CA7 | |
| SCHEMBL20809648 | 1.00 | ZDHHC7 (0.50) | ZDHHC7CA12CA14CA2CA7 | |
| SCHEMBL28534415 | 1.00 | ZDHHC7 (0.50) | ZDHHC7CA12CA14CA2CA7 | |
| SCHEMBL31578918 | 0.98 | ZDHHC7 (0.49) | ZDHHC7CA12CA14CA2CA7 | |
| SCHEMBL25542874 | 0.93 | FFAR4 (0.50) | TSHRMEN1KMT2AHSD17B10PPARG | |
| SCHEMBL19277209 | 0.93 | CA2 (0.53) | ZDHHC7CA12CA14CA2CA7 | |
| SCHEMBL26734355 | 0.93 | CA2 (0.53) | ZDHHC7CA12CA14CA2CA7 | |
| SCHEMBL16012604 | 0.92 | TSHR (0.52) | ZDHHC7CA12CA14CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12545931-B2 | Method for transfection into cardiomyocytes using cationic lipid | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2026-02-10 | — | — | US | disclosed |
| US-12479791-B2 | Cationic lipid | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2025-11-25 | — | — | US | disclosed |
| EP-3835287-B1 | CATIONIC LIPID | TAKEDA PHARMACEUTICALS CO (JP) | 2024-10-02 | — | — | EP | disclosed |
| CN-117304048-A | Cationic lipid | 武田药品工业株式会社 | 2023-12-29 | — | — | CN | disclosed |
| CN-112533893-B | Cationic lipid | 武田药品工业株式会社 | 2023-12-22 | — | — | CN | disclosed |
| US-20220145329-A1 | METHOD FOR TRANSFECTION INTO CARDIOMYOCYTES USING CATIONIC LIPID | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2022-05-12 | — | — | US | disclosed |
| US-20220098142-A1 | CATIONIC LIPID | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2022-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220098142-A1 | CATIONIC LIPID | LIPC, NPC1, LPCAT1 | ZDHHC7 194/4885CA12 1255/4885CA14 1713/4885 |
| US-12479791-B2 | Cationic lipid | LIPC, NPC1, LPCAT1 | ZDHHC7 194/4885CA12 1255/4885CA14 1713/4885 |
| US-12545931-B2 | Method for transfection into cardiomyocytes using cationic lipid | TNNT2, TNNC1, TNNI3 | ZDHHC7 329/4885CA12 3914/4885CA14 4192/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.